1. Home
  2. CPAC vs ALLO Comparison

CPAC vs ALLO Comparison

Compare CPAC & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • ALLO
  • Stock Information
  • Founded
  • CPAC 1949
  • ALLO 2017
  • Country
  • CPAC Peru
  • ALLO United States
  • Employees
  • CPAC N/A
  • ALLO N/A
  • Industry
  • CPAC Building Materials
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CPAC Industrials
  • ALLO Health Care
  • Exchange
  • CPAC Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • CPAC 475.3M
  • ALLO 427.7M
  • IPO Year
  • CPAC 2012
  • ALLO 2018
  • Fundamental
  • Price
  • CPAC $5.77
  • ALLO $2.17
  • Analyst Decision
  • CPAC Sell
  • ALLO Strong Buy
  • Analyst Count
  • CPAC 1
  • ALLO 10
  • Target Price
  • CPAC $6.00
  • ALLO $10.06
  • AVG Volume (30 Days)
  • CPAC 5.1K
  • ALLO 9.8M
  • Earning Date
  • CPAC 03-04-2025
  • ALLO 03-13-2025
  • Dividend Yield
  • CPAC 8.69%
  • ALLO N/A
  • EPS Growth
  • CPAC 17.75
  • ALLO N/A
  • EPS
  • CPAC 0.12
  • ALLO N/A
  • Revenue
  • CPAC $524,464,683.00
  • ALLO $43,000.00
  • Revenue This Year
  • CPAC N/A
  • ALLO N/A
  • Revenue Next Year
  • CPAC N/A
  • ALLO N/A
  • P/E Ratio
  • CPAC $9.19
  • ALLO N/A
  • Revenue Growth
  • CPAC 1.44
  • ALLO 26.47
  • 52 Week Low
  • CPAC $5.10
  • ALLO $1.32
  • 52 Week High
  • CPAC $6.65
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 49.77
  • ALLO 55.14
  • Support Level
  • CPAC $5.70
  • ALLO $1.32
  • Resistance Level
  • CPAC $6.00
  • ALLO $3.78
  • Average True Range (ATR)
  • CPAC 0.15
  • ALLO 0.36
  • MACD
  • CPAC -0.01
  • ALLO 0.10
  • Stochastic Oscillator
  • CPAC 31.88
  • ALLO 34.55

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: